CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2 Trial Evaluating αDC1 Vaccines Combined With Tumor-Selective Chemokine Modulation as Adjuvant Therapy After Surgical Resection of Peritoneal Surface Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02151448
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:38.537196+00:00
Published At: 2020-01-28T00:00:00+00:00
Record Updated At: 2020-07-20
Results Posted At: 2020-01-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface", "Malignant Peritoneal Mesothelioma", "Peritoneal Carcinomatosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-07-20"
protocolSection.identificationModule.nctId: "NCT02151448"
protocolSection.identificationModule.officialTitle: "A Phase 1/2 Trial Evaluating \u03b1DC1 Vaccines Combined With Tumor-Selective Chemokine Modulation as Adjuvant Therapy After Surgical Resection of Peritoneal Surface Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-01-28"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.